46 / 132
46
Informaciones
Psiquiátricas
2019 - n.º
235
ges and Depression. Psychiatric Clinics
of North America. 2018.
9.
Tunvirachaisakul C, Gould RL, Coulson
MC, Ward E V., Reynolds G, Gatherco-
le RL, et al. Predictors of treatment
outcome in depression in later life: A
systematic review and meta-analysis.
Journal of Affective Disorders. 2017.
10.
Szanto K, Galfalvy H, Vanyukov PM,
Keilp JG, Dombrovski AY. Pathways
to late-life suicidal behavior: Cluster
analysis and predictive validation of
suicidal behavior in a sample of older
adults with major depression. J Clin
Psychiatry. 2018;
11.
Kok RM, Reynolds CF. Management of
Depression in Older Adults. JAMA [In-
ternet]. 2017;317(20):2114–22.
12.
Valiengo L da CL, Stella F, Forlenza OV.
Mood disorders in the elderly: preva-
lence, functional impact, and manage-
ment challenges. Neuropsychiatr Dis
Treat. 2016;12:2105–14.
13.
Naismith SL, Norrie LM, Mowszows-
ki L, Hickie IB. The neurobiology
of depression in later-life: Clinical,
neuropsychological, neuroimaging and
pathophysiological features. Progress
in Neurobiology. 2012.
14.
Espinoza R, Kaufman A. Diagnosis and
Treatment of Late-Life Depression.
Psychiatr Times [Internet]. 2014;1–8.
15.
Delgado Silveira E, Muñoz García M,
Montero Errasquin B, Sánchez Caste-
llano C, Gallagher PF, Cruz-Jentoft AJ.
Prescripción inapropiada de medica-
mentos en los pacientes mayores: los
criterios STOPP/START. Rev Esp Geriatr
Gerontol. 2009;
16.
O’mahony D, O’sullivan D, Byrne S,
O’connor MN, Ryan C, Gallagher P.
STOPP/START criteria for potentially
inappropriate prescribing in older
people: Version 2. Age Ageing. 2015;
17.
Ghaemi S, Glick I, Ellison J. A com-
mentary on existential psychophar-
macologic clinical practice: ad-
vocating humanistic approach to
the “Med check.” J Clin Psychiatry.
2018;79(4):18ac12177.
Jorge Pla-Vidal